[Intraperitoneal perfusion of gemtuzumab-ozogamicin combined with allogeneic hematopoietic stem cell transplantation in intestinal solitary myeloid sarcoma: a case report and literature review]

Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):683-685. doi: 10.3760/cma.j.issn.0253-2727.2020.08.013.

[Article in Chinese]

Authors

W J Fu¹, L Gao¹, G H Lu¹, J M Yang¹

Affiliation

¹ Department of Hematology, Institute of Hematology, Changhai Hospital Affiliated to Navy Military Medical University, Shanghai 200433, China.

PMID: 32942825
PMCID: PMC7525164
DOI: 10.3760/cma.j.issn.0253-2727.2020.08.013

No abstract available

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Agents, Immunological / administration & dosage*
Gemtuzumab / administration & dosage*
Hematopoietic Stem Cell Transplantation*
Humans
Infusions, Parenteral
Perfusion
Sarcoma, Myeloid / therapy*

Substances

Antineoplastic Agents, Immunological
Gemtuzumab

Grants and funding

基金项目：国家自然基金面上项目（81770209）